Medipharm Labs Corp (LABS.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 36,458 | 27,946 | 21,366 | 38,627 | 42,116 |
| Marketable Securities | N/A | N/A | N/A | 0 | 200 |
| Receivables | 29,822 | 37,593 | 24,836 | 27,540 | 42,686 |
| Inventories | 31,683 | 40,329 | 45,093 | 51,486 | 54,086 |
| Other current assets | 3,045 | 18,911 | 0 | 0 | 287 |
| TOTAL | $101,008 | $127,656 | $93,351 | $119,701 | $140,853 |
| Non-Current Assets | |||||
| PPE Net | 44,808 | 45,552 | 43,962 | 42,233 | 34,919 |
| Investments And Advances | 191 | 191 | 191 | 189 | 189 |
| Other Non-Current Assets | 4,220 | 5,366 | 6,271 | 6,707 | 7,063 |
| TOTAL | $49,219 | $51,109 | $50,424 | $49,129 | $42,171 |
| Total Assets | $150,227 | $178,765 | $143,775 | $168,830 | $183,024 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 7,382 | 1,257 | 9,351 | 1,459 | 6,000 |
| Accounts payable and accrued liabilities | 2,116 | 5,646 | 11,697 | 19,057 | 41,636 |
| Accrued Expenses | 2,326 | 4,916 | 1,975 | 1,793 | N/A |
| Other current liabilities | N/A | 18,911 | N/A | N/A | 716 |
| TOTAL | $14,661 | $39,949 | $25,129 | $28,846 | $53,561 |
| Non-Current Liabilities | |||||
| Long Term Debt | 23,266 | 14,197 | N/A | 8,116 | N/A |
| Other Non-Current Liabilities | 8,778 | 7,692 | 572 | 320 | 2 |
| TOTAL | $31,303 | $21,594 | $553 | $8,757 | $484 |
| Total Liabilities | $45,964 | $61,543 | $25,682 | $37,603 | $54,045 |
| Shareholders' Equity | |||||
| Common Shares | 127,619 | 125,517 | 124,166 | 122,807 | 121,062 |
| Retained earnings | -43,591 | -28,631 | -25,277 | -8,189 | -4,969 |
| Other shareholders' equity | 21,358 | 21,095 | 19,776 | 16,929 | 12,888 |
| TOTAL | $105,386 | $117,981 | $118,665 | $131,547 | $128,981 |
| Total Liabilities And Equity | $151,350 | $179,524 | $144,347 | $169,150 | $183,026 |